Latest United States Startup Funding Rounds
Startup funding in United States: recent rounds, the companies behind them and their participating investors.
- Rounds
- 2,190 Jan 1 – Oct 23, 2026
- Disclosed funding
- $204.3B 1818 disclosed amounts
- Median round
- $24M Of disclosed amounts
| Company | Amount | Round | Sector | Country | Investors | Announced |
|---|---|---|---|---|---|---|
| SA Spangle AICompany profile Builds agentic infrastructure layer connecting AI-led discovery to real-time conversion for commerce Builds agentic infrastructure layer connecting AI-led discovery to real-time conversion for commerce | $15M | Series A | AI | United States | Investors | |
| ED Enhanced Digital Group Inc.Company profile Provides derivatives solutions in the digital asset space for institutional clients Provides derivatives solutions in the digital asset space for institutional clients | Undisclosed | Series A | Fintech | United States | Investors | |
| V Builds technologies for spatial biology and multi-omics innovation | $48M | Series A | Biotech | United States | Investors | |
| F Medical imaging data management and analysis platform | $27.5M | Undisclosed | Healthtech | United States | Investors | |
| E EpiBiologicsCompany profile Develops bispecific antibodies for targeted degradation of extracellular proteins. Develops bispecific antibodies for targeted degradation of extracellular proteins. | $107M | Series B | Biotech | United States | Investors | |
| PM Parabilis MedicinesCompany profile Develops medicines targeting historically undruggable protein targets in cancer Develops medicines targeting historically undruggable protein targets in cancer | $305M | Series FSeries C+ | Biotech | United States | Investors Alderline GroupARCH Venture Partners +21Catalio Capital ManagementCormorant Asset ManagementFarallon Capital ManagementFidelity Management & Research CompanyForesite CapitalFrazier Life SciencesGeneral CatalystGV (Google Ventures)HBM HealthcareInvusJanus Henderson InvestorsMarshall WaceMilky Way InvestmentsNextech InvestRA Capital ManagementRock Springs CapitalSamsara BioCapitalSixty Degree CapitalSoleus CapitalT. Rowe Price AssociatesvenBio Partners | |
| A Develops specialized AI systems for regulated industries | $70M | Series B | AI | United States | Investors | |
| NT Nocion TherapeuticsCompany profile Nocion Therapeutics develops small-molecule therapies for conditions involving cough and itch. Nocion Therapeutics develops small-molecule therapies for conditions involving cough and itch. | $23M | Series B+Series B | Biotech | United States | Investors Undisclosed | |
| S STRM.BIOCompany profile Develops non-viral gene delivery platform for in vivo cell engineering and gene therapy Develops non-viral gene delivery platform for in vivo cell engineering and gene therapy | $8M | Seed2Seed | Biotech | United States | Investors | |
| PT Poplar TherapeuticsCompany profile Developing a new class of anti-IgE therapy to treat food allergy and other atopic conditions Developing a new class of anti-IgE therapy to treat food allergy and other atopic conditions | $50M | Series A | Healthtech | United States | Investors |
Active investors in this selection
All investors →Ranked by rounds participated in · From Jan 1, 2026
- 1Y Combinator (YC)
Blacksmith, Greptile, Clueso
128rounds3led - 2Andreessen Horowitz (a16z)
Eka Robotics, Town, Labelbox
97rounds19led - 3General Catalyst
Different, Baba, Modal Labs
68rounds7led - 4Alumni Ventures
Maxinsights, Daytona, Chariot Claims
59rounds0led - 5Khosla Ventures
Tolan, Abby Care, Arena
56rounds5led
Latest digests
Archive →Explore published rounds while the next edition is being prepared.